SymBio Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 11.8%.

Top 16 shareholders own 15.31% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
4.01%	Rakuten Investment Management, Inc.	1,836,600	JP¥444.5m	0%	0.19%
3.02%	Herald Investment Management Ltd.	1,384,817	JP¥335.1m	0%	0.14%
2.57%	Fuminori Yoshida	1,179,700	JP¥285.5m	0%	no data
1.33%	Norihiro Kuroda	610,000	JP¥147.6m	0%	no data
0.94%	Sukenori Ito	430,000	JP¥104.1m	0%	no data
0.59%	Matsui Securities Co. Ltd., Asset Management Arm	271,000	JP¥65.6m	0%	0.27%
0.56%	SBI Holdings Inc., Asset Management Arm	255,980	JP¥61.9m	0%	0.02%
0.54%	Simplex Asset Management Co., Ltd.	246,900	JP¥59.7m	0%	0.04%
0.48%	Toshitaka Kashiwabara	220,025	JP¥53.2m	0%	no data
0.27%	Sumitomo Mitsui Financial Group Inc., Asset Management Arm	125,200	JP¥30.3m	0%	no data
0.26%	Tsuguyuki Fujimoto	121,000	JP¥29.3m	0%	no data
0.26%	Hiroshi Nishioka	120,000	JP¥29.0m	0%	no data
0.25%	Hiromi Toshishige	115,800	JP¥28.0m	0%	no data
0.13%	State Street Global Advisors, Inc.	60,600	JP¥14.7m	0%	no data
0.049%	Shigetoshi Matsumoto	22,500	JP¥5.4m	0%	no data
0.031%	Dimensional Fund Advisors LP	14,112	JP¥3.4m	0%	no data